BR0210697A - Methods and compositions useful for predicting blood-brain barrier permeation - Google Patents

Methods and compositions useful for predicting blood-brain barrier permeation

Info

Publication number
BR0210697A
BR0210697A BR0210697-3A BR0210697A BR0210697A BR 0210697 A BR0210697 A BR 0210697A BR 0210697 A BR0210697 A BR 0210697A BR 0210697 A BR0210697 A BR 0210697A
Authority
BR
Brazil
Prior art keywords
brain barrier
methods
compositions useful
barrier permeation
predicting blood
Prior art date
Application number
BR0210697-3A
Other languages
Portuguese (pt)
Inventor
Li Di
Edward Harvel Kerns
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BR0210697A publication Critical patent/BR0210697A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors

Abstract

"MéTODOS E COMPOSIçõES úTEIS PARA A PREVISãO DA PERMEAçãO DA BARREIRA SANGUE-CéREBRO". A presente invenção provê um método para a determinação in vitro da habilidade de um composto ou uma mistura de compostos em permear a barreira sangue-cérebro e uma composição de membrana útil para isso."METHODS AND USEFUL COMPOSITIONS FOR FORECASTING BLOOD-BRAIN BARRIER EXCHANGE". The present invention provides a method for determining in vitro the ability of a compound or mixture of compounds to permeate the blood-brain barrier and a membrane composition useful therefor.

BR0210697-3A 2001-06-29 2002-06-20 Methods and compositions useful for predicting blood-brain barrier permeation BR0210697A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30208501P 2001-06-29 2001-06-29
PCT/US2002/019736 WO2003003007A2 (en) 2001-06-29 2002-06-20 Methods and compositions useful for the prediction of blood-brain barrier permeation

Publications (1)

Publication Number Publication Date
BR0210697A true BR0210697A (en) 2004-09-21

Family

ID=23166189

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0210697-3A BR0210697A (en) 2001-06-29 2002-06-20 Methods and compositions useful for predicting blood-brain barrier permeation

Country Status (8)

Country Link
EP (1) EP1399539A2 (en)
JP (1) JP2005501230A (en)
AR (1) AR036121A1 (en)
AU (1) AU2002315398A1 (en)
BR (1) BR0210697A (en)
CA (1) CA2448746A1 (en)
MX (1) MXPA03011439A (en)
WO (1) WO2003003007A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE453119T1 (en) 2002-01-31 2010-01-15 Pion Inc METHOD AND DEVICE FOR MEASURING MEMBRANE PERMEABILITY
US8986781B2 (en) * 2005-10-27 2015-03-24 Corning Incorporated Immobilized multi-layer artificial membrane for permeability measurements (PAMPA)
DE102008007673A1 (en) * 2008-01-25 2009-07-30 Nimbus Biotechnologie Gmbh Determination of the permeability of substances through the blood-brain barrier
US10143187B2 (en) 2017-02-17 2018-12-04 Denali Therapeutics Inc. Transferrin receptor transgenic models
US10457717B2 (en) 2017-02-17 2019-10-29 Denali Therapeutics Inc. Engineered polypeptides
AU2018221731C1 (en) 2017-02-17 2021-11-18 Denali Therapeutics Inc. Engineered transferrin receptor binding polypeptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260210A (en) * 1989-09-27 1993-11-09 Rubin Lee L Blood-brain barrier model

Also Published As

Publication number Publication date
EP1399539A2 (en) 2004-03-24
JP2005501230A (en) 2005-01-13
CA2448746A1 (en) 2003-01-09
MXPA03011439A (en) 2004-04-05
WO2003003007A2 (en) 2003-01-09
WO2003003007A3 (en) 2003-05-22
AR036121A1 (en) 2004-08-11
AU2002315398A1 (en) 2003-03-03

Similar Documents

Publication Publication Date Title
BR0213207A (en) peptide remodeling and glycoconjugation
ECSP055910A (en) NEW CARBOXILIC ACIDS AND ITS ESTERS, MEDICATIONS CONTAINING THESE COMPOUNDS AND PROCEDURES FOR THEIR PREPARATION
BRPI0410630A (en) nk1 antagonist
BRPI0412321A (en) cleaning peroxide filtration membranes
BR0213612A (en) Compound, pharmaceutical composition, use of compound and method for treating disease or condition
BRPI0715579A2 (en) "compound, pharmaceutical composition and use of a compound"
NO20055652L (en) Lactate-containing pharmaceutical preparation and its use
DE602004021786D1 (en) TETRAHYDROISOCHINOLYLACETAMIDE DERIVATIVES FOR USE AS OREXINE RECEPTOR ANTAGONISTS
BR0211723A (en) Corineform bacteria that produce chemical compounds i
NO20051102L (en) Sulfonylamino-acetic acid derivatives
ECSP034850A (en) SALT CITRATE OF 5, 8, 14-TRIAZATETRACICLO [10.3.1.02,11.04,9] HEXADECA-2 (11), 3,5,7,9-PENTAENO AND PHARMACEUTICAL COMPOSITIONS OF THE SAME
IS2648B (en) Amino cyclohexyl ether compounds and their use
DK1436257T3 (en) Oxime analogs of 1-alpha, 25-dihydroxy-vitamin-D3 with low calcium effect
BR0206293A (en) Immunization Compositions and Methods of Use
BR0215148A (en) 5ht4 Partial Agonist Pharmaceutical Compositions
UY26057A1 (en) MODIFIED AMINO ACID AMIDES, MEDICINES CONTAINING THESE COMPOUNDS AND PROCEDURE FOR THEIR PREPARATION
BRPI0609765A8 (en) isoalkane mixture, method for the preparation thereof, cosmetic or pharmaceutical composition, and use of an isoalkane mixture
BR0100982A (en) Process for the preparation of deresorcinol derivatives
BR9909468A (en) Anti-bacterial compound, oral anti-plaque composition, and, process for promoting oral hygiene
BR0210697A (en) Methods and compositions useful for predicting blood-brain barrier permeation
ATE430160T1 (en) LIPOPEPTIDE STEREOISOMERS, METHOD FOR THE PRODUCTION THEREOF AND USEFUL INTERMEDIATE PRODUCTS
MY138542A (en) Biguanide and dihydrotriazine derivatives
BR0212353A (en) Compound, pharmaceutical composition, and use of a compound
BR0317229A (en) Composition and use of alfa7nachr complete agonist
BR0315178A (en) Erythropoietin: remodeling and glycoconjugation of erythropoietin

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]